Tamara Darsow

American Diabetes Association — United States

Medicine · Health Sciences

19h-index2.6kcitations26works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes Treatment and Management(13), Diabetes Management and Research(8), Cellular transport and secretion(5), Endoplasmic Reticulum Stress and Disease(4), Metabolism, Diabetes, and Cancer(4)

Publications26 total

Evaluation of Treatment Persistence in Individuals with Type 2 Diabetes in a Real-World Setting
Diabetes·2018· 1 cited
A Real-World Evaluation of the Association between Cardiovascular Outcomes and T2D Therapy
Diabetes·2018· 1 cited
American Diabetes Association’s Standards of Care: A Paradigm Shift in the Dissemination of Information
Diabetes Care·2018· 7 citedOpen Access
Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis
Diabetes·2016· 805 citedOpen Access
American Diabetes Association and JDRF Research Symposium: Diabetes and the Microbiome
Diabetes·2015· 34 citedOpen Access
Biologic Responses to Weight Loss and Weight Regain: Report From an American Diabetes Association Research Symposium
Diabetes·2015· 50 cited
Efficacy of GLP-1 Receptor Agonists and DPP-4 Inhibitors: Meta-Analysis and Systematic Review
Clinical Therapeutics·2012· 249 cited
The American Diabetes Association Diabetes Research Perspective
Diabetes·2012· 24 citedOpen Access
The American Diabetes Association Diabetes Research Perspective
Diabetes Care·2012· 40 citedOpen Access
Clinical relevance of anti‐exenatide antibodies: safety, efficacy and cross‐reactivity with long‐term treatment
Diabetes Obesity and Metabolism·2012· 148 cited
Incretin‐based therapies
Journal of Diabetes·2011· 57 citedOpen Access
PO43 - Les anticorps anti-exénatide ne réagissent ni avec le GLP-1 humain, ni avec le glucagon et n’altèrent ni l’efficacité, ni la sécurité d’un traitement par exénatide
Diabetes & Metabolism·2011
Pramlintide as an Adjunct to Basal Insulin: Effects on Glycemic Control and Weight in Patients with Type 2 Diabetes Mellitus
Insulin·2007· 3 cited
Pramlintide reduced markers of oxidative stress in the postprandial period in patients with type 2 diabetes
Diabetes/Metabolism Research and Reviews·2007· 22 cited
Pramlintide as An Adjunct to Insulin in Patients with Type 2 Diabetes in A Clinical Practice Setting Reduced A1C, Postprandial Glucose Excursions, And Weight
Diabetes Technology & Therapeutics·2007· 39 cited
Einfluss von Pramlintide als Zusatz zu intensiver Insulintherapie auf hsCRP und Adiponektin bei Patienten mit Typ 1 Diabetes
Diabetologie und Stoffwechsel·2007
Pramlintide in the treatment of diabetes
International Journal of Clinical Practice·2006· 19 cited
Is the metabolic syndrome a real clinical entity and should it receive drug treatment?
Current Diabetes Reports·2006· 8 cited
Pramlintide in the management of insulin-using patients with type 2 and type 1 diabetes
Vascular Health and Risk Management·2006· 60 cited
Exocytic Trafficking Is Required for Nicotine-induced Up-regulation of α4β2 Nicotinic Acetylcholine Receptors
Journal of Biological Chemistry·2005· 75 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Scott D. Emr(6), Robert E. Ratner(5), Juan P. Frías(5), David Maggs(3), Cameron W. Lush(3), William T. Cefalu(3), Richard A. Insel(2), Allison T. McElvaine(2), Mark Fineman(2), Kenneth Mace(2), M. Diamant(2), Brenda Cirincione(2), Michael Trautmann(2), David J. Katzmann(2), Erika Gebel Berg(2), Vivian Fonseca(2), M. Sue Kirkman(2), Gayle M. Lorenzi(2), M. R. Petersen(2), Ellen Thiel(2)